title: [Has the Medical Products Agency left the evidence-based medicine? The banning of SSRI to children and adolescents is unfounded].
authors.affiliation: Psykiatriska kliniken, Karolinska Universitetssjukhuset Huddinge. Goran.lsacsson@neurotec.ki.se
authors.forename: Göran
authors.initials: G
authors.lastname: Isacsson
authors.forename: Susanne
authors.initials: S
authors.lastname: Bejerot
mesh_terms: D000293:Adolescent; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013405:Suicide
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors